EBCOG position statement on Inequalities in screening for cervical and breast cancer.

Breast Cancer Cancer detection Cervix EBCOG Europe Gynaecology HPV Health inequalities National policy Population Prevention Screening Survey

Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 25 9 2023
pubmed: 10 9 2023
entrez: 9 9 2023
Statut: ppublish

Résumé

Gynaecological cancers, namely breast and cervical cancer represent a high burden in women's health. It is well established that cervical and breast cancer screening programmes are effective in reducing morbidity and mortality. It is of the most importance to define strategies to provide a universal access to screening. In European countries, significant progress has been made over the past years concerning screening strategies, namely the choice of screening test, its frequency as well as the age to start and stop the screening. Introduction of Human Papillomavirus vaccination programmes is also making a measurable impact to reduce cervical cancer prevalence and mortality. Our survey has shown a variation among European countries in delivery of cervical and breast cancer screening programmes. These variations can be due to organizational, economic or cultural reasons. The European Board and College of Obstetrics and Gynaecology calls for an implementation of a unified policy of prevention, screening and early detection of cervical and breast cancer across Europe to optimize clinical outcomes and reduce variations.

Identifiants

pubmed: 37689510
pii: S0301-2115(23)00692-9
doi: 10.1016/j.ejogrb.2023.08.386
pii:
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-218

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Márcia Vieira-Coimbra (M)

Department of Gynaecology and Obstetrics of Centro Hospitalar Tondela-Viseu EPE, Viseu, Portugal. Electronic address: 8507@hstviseu.min-saude.pt.

Nuno Nogueira-Martins (N)

Department of Gynaecology and Obstetrics of Centro Hospitalar Tondela-Viseu EPE, Viseu, Portugal.

Rafal Zadykowicz (R)

Department of Obstetrics, Perinatology and Gynaecology, Medical University of Warsaw, Poland.

Hugo Rodrigues Gaspar (HR)

Department of Gynaecology and Obstetrics of Hospital Central do Funchal, Madeira, Portugal.

Jean Calleja-Agius (J)

Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Malta.

Maja Pakiz (M)

Department for Gynaecologic and Breast Oncology, University Medical Centre Maribor, Slovenia.

Sambit Mukhopadhyay (S)

Department of Obstetrics and Gynaecology, Norfolk and Norwich University Hospital, Norwich, UK.

Tahir Mahmood (T)

Visiting Consultant Gynaecologist Spire Murrayfield Hospital, Edinburgh, Scotland and Chair Standing Committee on Standards of Care and Position Statements of EBCOG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH